15110dkk
0,7 %
Date:2024-04-23Time:16:59:38Latest report:Q4-2023List:Large CapTicker:BAVA
Market Cap:11 801 mdkkEnterprise Value:10 078 mdkkNet Sales:7 062 mdkkEarnings:1 475 mdkkEmployees:0ISIN:DK0015998017

Ratios

10-year key figure history for Bavarian Nordic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Bavarian Nordic with index and moving average MA50 and MA200.

Stockprice:151,10
MA50:158,73
MA200:156,68
Price/MA200:-3,6 %
RSI (14):46,8
Price/MA50:-4,8 %

Description

Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Biotechnology